REPLIGEN CORP (RGEN) Free cash flow 2016–2025
REPLIGEN CORP (RGEN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$93.9MFY2025 · since FY2016: $3.2M → $93.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $93.9M | -37.3% |
| FY2024 | $149.7M | +92.7% |
| FY2023 | $77.7M | -10.9% |
| FY2022 | $87.2M | +68.0% |
| FY2021 | $51.9M | +29.3% |
| FY2020 | $40.2M | -17.5% |
| FY2019 | $48.7M | +120.1% |
| FY2018 | $22.1M | +84.5% |
| FY2017 | $12.0M | +275.4% |
| FY2016 | $3.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice